Paperpal Prime Logo

Lupus : Impact Factor & More

eISSN: 1477-0962pISSN: 0961-2033

Key Metrics

CiteScore
4.5
H-Index
114
Impact Factor
< 5
SJR
Q2Rheumatology
SNIP
1.08
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Lupus

Lupus Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
Overview
Publisher SAGE PUBLICATIONS LTD
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year1991
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Lupus ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Lupus

Stigma, discrimination-related events, and determinants among adult people living with systemic lupus erythematosus (SLE): Systematic review and indicator-level meta-analysis.
  • 8 Aug 2026
  • Lupus
Network meta-analysis of triple immunosuppressive therapies and standard of care for induction of remission of active lupus nephritis.
  • 5 Aug 2026
  • Lupus
Validation and prognostic utility of SLERPI in a single-centre retrospective Central European cohort.
  • 5 Aug 2026
  • Lupus
CircSMURF2 alleviates cell apoptosis by binding DIABLO promote ubiquitination and its expression level and clinical significance in lupus nephritis.
  • 5 Aug 2026
  • Lupus
Comparative study of adverse drug reactions associated with anifrolumab and belimumab for the treatment of systemic lupus erythematosus.
  • 1 Aug 2026
  • Lupus
Factors associated with changes in self-efficacy in patients with systemic lupus erythematosus. Data from the almenara lupus cohort.
  • 1 Aug 2026
  • Lupus
Stigma, discrimination-related events, and determinants among adult people living with systemic lupus erythematosus (SLE): Systematic review and indicator-level meta-analysis.
  • 8 Aug 2026
  • Lupus
Network meta-analysis of triple immunosuppressive therapies and standard of care for induction of remission of active lupus nephritis.
  • 5 Aug 2026
  • Lupus
Validation and prognostic utility of SLERPI in a single-centre retrospective Central European cohort.
  • 5 Aug 2026
  • Lupus
CircSMURF2 alleviates cell apoptosis by binding DIABLO promote ubiquitination and its expression level and clinical significance in lupus nephritis.
  • 5 Aug 2026
  • Lupus
Comparative study of adverse drug reactions associated with anifrolumab and belimumab for the treatment of systemic lupus erythematosus.
  • 1 Aug 2026
  • Lupus
Factors associated with changes in self-efficacy in patients with systemic lupus erythematosus. Data from the almenara lupus cohort.
  • 1 Aug 2026
  • Lupus

FAQs on Lupus